SATHISH DYAWANAPELLY | Pharmacology and Drug Development | Young Scientist Award

Published on by Life Science

Young Scientist Award

SATHISH DYAWANAPELLY
Affiliation Institute of Chemical Technology (ICT), Mumbai
Country India
Scopus ID 56293760300
Documents 39
Citations 1947
h-index 24
Subject Area Pharmacology and Drug Development
Event World Life Science Awards

SATHISH DYAWANAPELLY is a researcher associated with the Institute of Chemical Technology (ICT), Mumbai, whose scholarly work has focused on pharmacology, nanomedicine, drug delivery systems, biomaterials, and pharmaceutical innovation. His research portfolio demonstrates sustained contributions to the advancement of drug development methodologies, polymer therapeutics, pulmonary delivery systems, nanovaccines, and translational pharmaceutical sciences. The combination of publication output, citation performance, and interdisciplinary research engagement provides a basis for consideration within academic recognition programs such as the Young Scientist Award.[1]

Abstract

This article presents an academic overview of SATHISH DYAWANAPELLY and evaluates his suitability for recognition through the Young Scientist Award. The assessment is based on publicly available scholarly indicators including publication productivity, citation performance, research specialization, and documented contributions to pharmaceutical sciences and drug delivery technologies. His work spans nanomedicine, cancer therapeutics, pulmonary formulations, biomimetic nanovaccines, and advanced pharmaceutical engineering, demonstrating interdisciplinary engagement within life science research.[1][2]

Keywords

Nanomedicine, Drug Delivery Systems, Pharmacology, Polymer Therapeutics, Pulmonary Drug Delivery, Pharmaceutical Sciences, Cancer Therapy, Biomaterials, Nanovaccines, Life Sciences.

Introduction

The development of modern therapeutics increasingly relies on innovative drug delivery technologies capable of improving efficacy, safety, and patient outcomes. Researchers working at the intersection of pharmaceutical sciences and nanotechnology contribute substantially to this objective. SATHISH DYAWANAPELLY has developed a research profile centered on advanced delivery systems, polymer-based therapeutics, and translational pharmaceutical technologies, contributing to emerging areas of life science research.[2][3]

Research Profile

Based at the Institute of Chemical Technology (ICT), Mumbai, SATHISH DYAWANAPELLY has established a scholarly record characterized by publications in internationally recognized journals and interdisciplinary collaborations. His Scopus metrics indicate 39 indexed documents, 1,947 citations, and an h-index of 24, reflecting measurable research visibility and influence within pharmacology and drug development.[1]

  • Specialization in pharmacology and advanced drug delivery systems.
  • Research involvement in nanomedicine and biomaterial-based therapeutics.

Research Contributions

The research contributions of SATHISH DYAWANAPELLY encompass several areas of pharmaceutical innovation. His studies have explored polymer therapeutics, pulmonary drug delivery systems, nanoparticle engineering, biomimetic nanovaccines, and cancer-targeted delivery technologies. These investigations address practical challenges associated with therapeutic effectiveness, bioavailability, and targeted treatment strategies.[2]

  • Polymer therapeutics and pharmacokinetic optimization.
  • Nanovaccine development and biomimetic delivery technologies.
  • Pulmonary drug delivery approaches for chronic diseases.

Publications

Selected publications associated with SATHISH DYAWANAPELLY demonstrate engagement with contemporary pharmaceutical research topics and high-impact translational applications.[2]

  1. The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Biodistribution.
  2. Understanding the Nano-Bio Interactions Using Real-Time Surface Plasmon Resonance Tool.
  3. Multifaceted Therapeutic Applications of Biomimetic Nanovaccines.

Research Impact

Citation metrics, publication quality, and subject relevance collectively indicate that the research activities of SATHISH DYAWANAPELLY have generated measurable scholarly attention. The citation count of 1,947 and h-index of 24 suggest that multiple publications have influenced subsequent investigations within pharmaceutical sciences and drug delivery research. Such indicators are commonly considered when evaluating research significance and scientific visibility.[1]

Award Suitability

The Young Scientist Award recognizes emerging and accomplished researchers who demonstrate innovation, scientific productivity, and meaningful contributions within their disciplines. Based on available scholarly indicators, SATHISH DYAWANAPELLY exhibits characteristics aligned with such recognition, including interdisciplinary research output, citation impact, active publication record, and contributions to pharmaceutical innovation. His work on advanced therapeutic delivery technologies aligns with contemporary priorities in life science and healthcare research.[1][2]

Conclusion

SATHISH DYAWANAPELLY has developed a notable academic profile within pharmacology and drug development through contributions to nanomedicine, drug delivery systems, biomaterials, and therapeutic innovation. The combination of publication productivity, citation performance, and interdisciplinary research engagement supports consideration for academic recognition programs such as the Young Scientist Award under the World Life Science Awards framework.[1]

References

  1. Sampathi, S., Tiriya, P. K., Dodoala, S., Junnuthula, V., & Dyawanapelly, S. (2022). Development of biocompatible ciprofloxacin–gold nanoparticle coated sutures for surgical site infections. Pharmaceutics, 14(10), Article 2130.
    https://doi.org/10.3390/pharmaceutics14102130
  2. Parihar, A., Prajapati, B. G., Paliwal, H., Shukla, M., Khunt, D., Bahadure, S. D., Dyawanapelly, S., & Junnuthula, V. (2023). Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis. Drug Discovery Today, 28(10), Article 103729
    https://doi.org/10.1016/j.drudis.2023.103729
  3. Iyer, G., Dyawanapelly, S., Jain, R., & Dandekar, P. (2022). An overview of oral insulin delivery strategies (OIDS).
    https://doi.org/10.1016/j.ijbiomac.2022.03.144

Muath Alkadi | Life Sciences Innovation | Research Excellence Award

Published on by Life Science

Dr. Muath Alkadi | Life Sciences Innovation | Research Excellence Award

University of Hafr Al Batin | Saudi Arabia

Dr. Muath A. Alkadi is an accomplished physicist specializing in accelerator physics, radiation science, and advanced energy materials. His research focuses on electron beam dynamics, compact particle accelerators, and Compton X-ray sources, contributing to innovations in medical isotope production and imaging technologies. He has extensive experience in nuclear technologies, dosimetry, and radiation systems simulation. His work also spans photovoltaic materials, perovskite solar cells, and computational modeling using machine learning and density functional theory. Through interdisciplinary collaborations, he advances sustainable energy solutions and high-performance optoelectronic systems while supporting cutting-edge research initiatives in both theoretical and experimental physics.

Citation Metrics (Scopus)

  500
  300
  100
    20
     0

Citations
331

Documents
20

h-index
9

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications

Neha Vats | Medical Physics | Best Researcher Award

Published on by Life Science

Dr. Neha Vats | Medical Physics | Best Researcher Award

Heidelberg University | Germany

Dr. Neha Vats is a postdoctoral researcher in Medical Imaging and Spectroscopy at the Central Institute of Mental Health, Mannheim, Germany, with a strong research foundation in MRI, CT, and multinuclear MRS. Her expertise lies in quantitative image analysis, medical image processing, and the development of advanced imaging protocols. She has contributed significantly to translational neuroimaging and oncology through the optimization of CT perfusion techniques and neurochemical imaging in psychiatric populations. Her scholarly output includes five peer-reviewed publications in high-impact journals such as Scientific Reports and Magnetic Resonance Imaging, addressing topics like pancreatic CT perfusion standardization, perfusion model development, and machine-learning-based tumor differentiation. According to her Scopus profile, she has 5 documents, an h-index of 4, and 28 citations, reflecting strong research visibility and growing academic impact in biomedical imaging. Dr. Vats’s technical proficiency spans MATLAB, C++, perfusion mathematical modeling, and quantitative neuroimaging, with research interests focusing on advanced spectroscopy methods and metabolic brain characterization. Her ongoing projects on ME/CFS and aggression-related brain changes exemplify her commitment to integrating imaging physics with neuroscience for clinical translation and sustainable advancements in medical diagnostics.

Profiles: Scopus | Orcid | Research Gate 

Featured Publications

Vats, N., Mayer, P., Kortes, F., Klauß, M., Grenacher, L., Stiller, W., Kauczor, H.-U., & Skornitzke, S. Evaluation and timing optimization of CT perfusion first pass analysis in comparison to maximum slope model in pancreatic adenocarcinoma. Scientific Reports, 13, Article 10865.

Skornitzke, S., Vats, N., Mayer, P., Kauczor, H.-U., & Stiller, W. Pancreatic CT perfusion: Quantitative meta-analysis of disease discrimination, protocol development, and effect of CT parameters. Insights into Imaging, 14, Article 1471.

Vats, N., Sengupta, A., Gupta, R. K., Patir, R., Vaishya, S., Ahlawat, S., Saini, J., Agarwal, S., & Singh, A. Differentiation of pilocytic astrocytoma from glioblastoma using a machine-learning framework based upon quantitative T1 perfusion MRI. Magnetic Resonance Imaging, 97, 63–71.

Skornitzke, S., Vats, N., Kopytova, T., Tong, E. W. Y., Hofbauer, T., Weber, T. F., Rehnitz, C., von Stackelberg, O., Maier-Hein, K., & Stiller, W. Asynchronous calibration of quantitative computed tomography bone mineral density assessment for opportunistic osteoporosis screening: Phantom-based validation and parameter influence evaluation. Scientific Reports, 12, Article 20478

Marius Sipping | Pharmacology | Best Researcher Award

Published on by Life Science

Dr. Marius Sipping | Pharmacology | Best Researcher Award

Slovak Academy of Sciences | Slovakia

Dr. Marius Sipping is a postdoctoral researcher at the Slovak Academy of Sciences, specializing in biochemistry, pharmacology, and biotechnology. His work focuses on the exploration and characterization of bioactive natural compounds with therapeutic potential against cancer, autoimmune, and infectious diseases. With 10 peer-reviewed journal publications and one authored book, his research has significantly contributed to the understanding of polysaccharide-rich fractions from Ganoderma resinaceum and their antioxidant, anti-inflammatory, and anti-metastatic properties. He has completed five major research projects that integrate molecular biology and translational pharmacology. His citation records reflect his growing global impact, with an h-index of 6 on ResearchGate, 3 on Web of Science. These indices underscore his citation influence and scientific reach within the biomedical research community. His international collaborations with researchers across Africa, India, Slovakia, Italy, and France have advanced translational applications of natural compounds for cancer and inflammatory disease therapeutics. His interdisciplinary expertise in immunopharmacology, cancer biology, and phytomedicine demonstrates a strong commitment to developing innovative nano-delivery systems and data-driven therapeutic strategies, positioning him as a rising contributor to global life science research.

Profiles: Scopus | Orcid | Research ID

Featured Publications

Sipping, M., Thakur, D., Singh, B., Njamen, D., & Mukherjee, S. Polysaccharide extract of Ganoderma resinaceum restricts breast cancer progression in vitro by intervening in epithelial–mesenchymal transition and cancer stemness. Revista Brasileira de Farmacognosia.

Sipping, M., Sathish Kumar, T., & Kamdem, N. Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts. Journal of Complementary and Integrative Medicine.

Kamga Silihe, K., Defo Mbou, W., Ngo Pambe, J. C., Kenmogne, L. V., Fotso Maptouom, L., Sipping, M. T. K., Zingue, S., & Njamen, D. Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats. BMC Complementary Medicine and Therapies, 23, 4073.

Nana Tchoupang, E., Yadji, V., Wangbara, J. B., Sipping, M. T. K., Zingue, S., Njamen, D., & Mutalik, S. In vitro and in vivo antiproliferative actions of Solanum gilo Raddi (Solanaceae) fruit extract on breast tissues. Advances in Pharmacological and Pharmaceutical Sciences, 2022, 6834626.

Kamga Silihe, K., Zingue, S., Sipping, M. T. K., Busuioc Cazanevscaia, A., Dediu Botezatu, A. V., Njamen, D., & Dinica, R. M. The antioxidant potential of Ficus umbellata Vahl (Moraceae) that accelerates in vitro and the in vivo anti-inflammatory protective effects. Applied Sciences, 12(18), 9070

Annamaria Biroccio | Molecular Biology | Best Researcher Award

Published on by Life Science

Dr. Annamaria Biroccio | Molecular Biology | Best Researcher Award

IRCCS-Regina Elena National Cancer Institute | Italy

Dr. Annamaria Biroccio, PhD (Microbiology, University of Messina) is a Senior Investigator at the Regina Elena National Cancer Institute (IRE-IFO), Rome, with over two decades of experience in cancer molecular biology and telomere research. Her work focuses on elucidating the mechanisms regulating telomere function and their implications in cancer progression, alongside developing pharmacological strategies targeting telomeres for anticancer therapy. She has published extensively in high-impact journals, contributing over 115 peer-reviewed papers on telomere biology, DNA damage response, and targeted therapies. According to her CV, Dr. Biroccio holds an H-index of 44, reflecting substantial influence in the field, with more than 6124 citations across her publications. Her research leadership is underscored by principal investigator roles in major national and international grants, including AIRC, CNR, and EU FP7 programs. She is also co-owner of two patents related to telomere-targeting therapeutics for triple-negative breast cancer. In recognition of her contributions, she has received multiple awards such as the Mascia Brunelli Award and Young Investigator Award. Beyond research, Dr. Biroccio has significantly contributed to scientific training as a tutor for numerous national fellowship programs and serves on editorial boards of prominent cancer research journals

Profiles: Scopus | Orcid | Researcher ID 

Featured Publications

Dinami, R., Petti, E., Ostano, P., Iachettini, S., Rizzo, A., Maresca, C., Zizza, P., Di Vito, S., Porru, M., D’Angelo, C., Sibilio, P., De Nicola, F., Russo, R., Di Benedetto, A., Palange, A., Fanciulli, M., Chambery, A., Gilson, E., & Biroccio, A. (2025). Multi-omics analyses integration reveals a novel TRF2–miR-181a-5p–S100A10 regulatory axis in colon cancer. Cellular and Molecular Biology Letters, 30(1), 121.

Petti, E., Di Vito, S., Dinami, R., Porru, M., Marchesi, S., Lohuis, J., Zizza, P., Iachettini, S., Salvati, E., D’Angelo, C., Rizzo, A., Maresca, C., Ascione, F., Di Benedetto, A., Buglioni, S., Sacconi, A., Ostano, P., Li, Q., Stoppacciaro, A., Leonetti, C., van Rheenen, J., Maiuri, P., Scita, G., & Biroccio, A. (2025). TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple-negative breast cancer. Cell Death & Disease, 16(1), 224.

Pirota, V., Iachettini, S., Platella, C., Zizza, P., Fracchioni, G., Di Vito, S., Carachino, A., Battistini, F., Orozco, M., Freccero, M., Biroccio, A., & Doria, F. (2025). Naphthalene diimide–naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes. Nucleic Acids Research, 53(7), gkaf301.

Russomanno, P., Zizza, P., Cerofolini, L., D’Aria, F., Iachettini, S., Di Vito, S., Amato, J., Fragai, M., Pagano, B., & Biroccio, A. (2025). Expanding the functions of KHSRP protein: Insights into DNA G-quadruplex binding. Advanced Science, 12(8), e2410086.

Pirota, V., Salvati, E., Risoldi, C., Manoli, F., Rizzo, A., Zizza, P., Biroccio, A., Freccero, M., & Manet, I. (2025). Core-extended naphthalene diimide dyads as light-up probes with targeted cytotoxicity toward tumor cells. Biomolecules, 15(2), 311.

Marina A | Drug Development | Clinical Life Science Awards

Published on by Life Science

Prof. Marina A | Drug Development | Clinical Life Science Award

Prof. Marina A | Annamalai University | India

Dr. Marina A., Pharm.D., Ph.D., has established a strong academic and research profile with significant contributions in clinical pharmacy and pharmacology, particularly focusing on polycystic ovary syndrome (PCOS) through randomized controlled trials and high-quality publications. She has authored 1 Scopus-indexed publications, including both research and review articles published in reputed Q1 and Q2 journals such as Inflammopharmacology (IF 5.3), Current Medical Research & Opinion (IF 2.3), European Journal of Obstetrics & Gynecology (IF 2.1), and BMC Nephrology (IF 2.4). Her research has already attracted citations, with her citation count exceeding 120, and she has accumulated a total of 4 Scopus documents, reflecting her growing visibility in the scientific community. Her h-index is 5, which demonstrates not only productivity but also impactful research that is being referenced by peers globally. Alongside publishing, Dr. Marina also serves as a reviewer for respected journals like Reproductive Sciences and Inflammopharmacology, further highlighting her academic credibility. With expertise in regulatory medical writing, teaching, and clinical trial management, she has built a balanced profile bridging academia, industry, and clinical research. Her continuous scholarly output, growing citation base, and expanding peer review roles position her as a promising researcher with strong future potential in life sciences.

Profiles: Scopus | Orcid | LinkedIn

Featured Publications

Marina, A. (in press). Exploring the role of pentoxifylline as a renal protector in diabetic kidney disease: A comprehensive review. BMC Nephrology. Springer Nature. (Q2, IF 2.4, CiteScore 4.1).

Marina, A. (2025). Resveratrol: Potential therapeutic effects on ocular health. Inflammopharmacology, Springer Nature. (Q1, IF 5.3, CiteScore 8.4).

Marina, A. (2025). Effectiveness of acarbose plus metformin and acarbose plus myo-inositol dual combination therapy in alleviating the metabolic and endocrinological complications of PCOS. European Journal of Obstetrics & Gynecology and Reproductive Medicine, Elsevier. (Q2, IF 2.1, CiteScore 4.6).

Marina, A. (2025). Therapeutic potential of acarbose in ameliorating the metabolic and endocrinological complications of polycystic ovarian syndrome: A review. Current Medical Research & Opinion, Taylor & Francis. (Q1, IF 2.3, CiteScore 4.2).

Marina, A. (2025). Clinical implications of acarbose plus myo-inositol therapy on the thyroid profile of women with PCOS. Journal of Pharmacy and Pharmacognosy Research, (Q2, IF 1.2, CiteScore 3.0).

Jes Rust | Life Sciences Innovation | Best Researcher Award

Published on by Life Science

Prof. Dr. Jes Rust | Life Sciences Innovation | Best Researcher Award

Prof. Dr. Jes Rust | Bonner Institut fur Organismische Biologie (BIOB) | Germany

Prof. Dr. Jes Rust is an outstanding candidate for the Best Researcher Award, with an impressive scholarly record: he has published  41 documents, garnered 1,800 citations, and holds an h-index of about 46, evidence of both consistent productivity and strong impact in invertebrate palaeontology and evolutionary biology. His work, covering the evolution, phylogeny and paleobiology of insects, the early evolution of arthropods, molluscs, and theoretical aspects of phylogeny and systematics, has not only enriched fundamental scientific understanding but also shaped disciplinary debates. Since his habilitation, and especially in his long tenure as Professor at the University of Bonn, Jes Rust has combined rigorous field and laboratory research with high-quality publications and editorial leadership (e.g. editorship of Palaeontographica A), further amplifying his influence in the scientific community. His citation count and h-index reflect that many of his papers are regularly referenced, confirming their lasting relevance. In addition, his leadership roles in scientific societies and committees demonstrate recognition by peers. Taken together, his documents, citations, and metric indicators make Prof. Dr. Jes Rust an eminently suitable laureate for the Best Researcher Award.

Profile: Scopus

Featured Publications

Jiang, H., Moulds, M. S., Blank, S. M., Rust, J., Wedmann,  Wang, B. (2025). Sounds from the Eocene: The first singing cicada from the Messel Pit, Germany. Scientific Reports, 15, Article 12826.

Rust, J., & McCoy, V. E. (2025). Fossilisation ecology – A more complete concept of taphonomy. Trends in Ecology & Evolution. Advance online publication.

Jiang, H., Szwedo, J., Labandeira, C. C., Chen, J., Moulds, M. S., Mähler, B., Muscente, A. D., Zhuo, D., Nyunt, T. T., Zhang, H., Wei, C., Rust, J., & Wang, B. (2024). Mesozoic evolution of cicadas and their origins of vocalization and root feeding. Nature Communications, 15(1), Article 376.

Pratap Mali | Drug Development | Best Researcher Award

Published on by Life Science

Prof. Pratap Mali | Drug Development | Best Researcher Award

University of Rajasthan, Jaipur | India

Dr. Pratap Chand Mali is a Professor in the Department of Zoology, University of Rajasthan, Jaipur, specializing in reproductive biology and physiology with a strong research focus on antifertility effects of medicinal plants and natural products. His academic profile is supported by a notable citation record, with 636 citations, an h-index of 12, and an i10-index of 16, reflecting his scholarly contributions and impact in the field. Over the years, he has authored numerous scientific documents and research articles, many of which explore innovative strategies for fertility regulation, contraceptive development, and reproductive health using phytochemicals and natural extracts. His publications span international journals, conferences, and symposiums, indicating both national and global engagement in advancing reproductive bioscience. In addition to his research, Prof. Mali has played significant editorial roles across multiple reputed journals and has been an invited speaker at high-profile scientific conferences worldwide. His research portfolio demonstrates a consistent dedication to addressing reproductive health challenges while exploring safe, effective, and reversible contraceptive methods. With his substantial output of academic documents, coupled with steady citation growth, Prof. Mali continues to influence the domains of reproductive biology, contraceptive innovation, and natural product pharmacology.

Profiles: Orcid | Scopus

Featured Publication

Targeting IDO1 in Huntington’s Disease: Network Pharmacology and Preclinical Evidence from Coffea arabica

Soumitra Sahana | Metabolomics | Best Researcher Award

Published on by Life Science

Mr. Soumitra Sahana | Metabolomics | Best Researcher Award

Birbhum Pharmacy School | India

Soumitra Sahana is an emerging researcher in pharmacognosy with an impressive academic and professional trajectory. Currently serving as an Assistant Professor at Birbhum Pharmacy School, he specializes in phytochemical extraction, isolation, molecular docking, MD simulation, and in-vitro assays. His academic background includes a Master of Pharmacy in Pharmacognosy with distinction and a Bachelor of Pharmacy with excellent grades. Soumitra has authored and co-authored several impactful publications across journals such as Functional & Integrative Genomics, Plant Biotechnology Reports, Natural Products and Bioprospecting, and Current Indian Science, with his research contributions earning 304 citations, an h-index of 5, and an i10-index of 4. His projects range from the bioassay-guided fractionation of Ficus religiosa leaves for Alzheimer’s management to developing AI-based biomedical imaging systems for cancer screening. In addition, he has been actively engaged in conferences, workshops, and industrial training, which strengthen his practical expertise in natural product research and pharmaceutical sciences. His skills extend to advanced computational tools such as Maestro, Pymol, PyRx, and Discovery Studio Visualizer, along with proficiency in chromatographic and spectroscopic instrumentation. With a growing publication record and a balanced profile of laboratory and computational expertise, Soumitra Sahana represents a promising researcher bridging traditional pharmacognosy with modern biomedical applications

Profile: Orcid 

Featured Publications

Multi-omics approaches: transforming the landscape of natural product isolation

Marjo-Riitta Jarvelin | Life Sciences Innovation | Best Researcher Award

Published on by Life Science

Prof. Dr. Marjo-Riitta Jarvelin | Life Sciences Innovation | Best Researcher Award

Imperial College London | United Kingdom

Professor Marjo-Riitta Järvelin is an internationally recognized scientist in lifecourse epidemiology, currently serving as Professor and Chair at Imperial College London. Her exceptional contributions span the design and management of the Northern Finland Birth Cohorts (NFBCs), pioneering large-scale longitudinal studies that have shaped global understanding of how prenatal and early-life exposures affect health outcomes across the lifespan. She has authored 1013 publications, many in high-impact journals such as Nature, Science, and NEJM, achieving over 149,230 citations and an h-index greater than 160 (Scopus) with a D-index of 185 (as of May 2025). Ranked 261st in medicine globally and among the top 32 female scientists worldwide, her work has driven groundbreaking discoveries including the role of the FTO gene in obesity, genetic determinants of metabolic and cardiovascular risks, and long-term effects of maternal smoking. Her leadership has been instrumental in EU and NIH-funded projects, advancing novel methodologies like the Bayesian Lifecourse Structural Equation Model (BLSEM). In addition to research excellence, she has supervised 37 PhDs, mentored next-generation scientists, and contributed significantly to translational science and policy. Professor Järvelin’s scholarly impact, global collaborations, and outstanding citation metrics firmly establish her as a leading candidate for the Best Researcher Award

Profile: Orcid

Featured Publications

Vitamin D Status in Women with a History of Infertility and Decreased Fecundability: A Population-Based Study

Influence of Farm Environment on Asthma during the Life Course: A Population-Based Birth Cohort Study in Northern Finland

25-Hydroxyvitamin D concentration and leukocyte telomere length in young adults: Findings from the Northern Finland birth cohort 1966

Accelerometer-measured physical activity and sedentary time differ according to education level in young adults